← Back to Search

90Second IBD for Inflammatory Bowel Disease

N/A

Recruiting

Research Sponsored by Jennifer Jones

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult, resident of Canada, diagnosis of IBD, access to a computer or cell phone

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 12

Awards & highlights

Study Summary

This trial will explore a novel way to help IBD patients manage their psychological issues, and improve their quality of life.

Who is the study for?

This trial is for adults living in Canada who have been diagnosed with Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis. Participants must have access to a computer or cell phone.Check my eligibility

What is being tested?

The '90Second IBD' intervention, an online health letter delivered weekly, is being tested to see if it improves the quality of life and self-efficacy in IBD patients by providing integrated medical and psychosocial information.See study design

What are the potential side effects?

Since '90Second IBD' involves receiving educational health letters, there are no direct physical side effects associated with typical medical interventions. However, individual reactions to the content may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

IBD Specific Quality of life

Self Efficacy

Secondary outcome measures

Participant Satisfaction with 90SecondIBD

Trial Design

1Treatment groups

Experimental Treatment

Group I: 90Second IBDExperimental Treatment1 Intervention

Participants will receive 90SecondIBD weekly at no charge via text message or email linked to a website.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Jennifer JonesLead Sponsor

2 Previous Clinical Trials

302 Total Patients Enrolled

90 Second HealthUNKNOWN

TakedaIndustry Sponsor

1,203 Previous Clinical Trials

4,177,444 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the intake capacity for this research endeavor?

"Confirmed. The clinicaltrials.gov page for this medical trial, which was initially published on June 7th 2023, shows that 500 participants are being sought at a single site. This information was last updated on November 27th 2023."

Answered by AI

Are there still opportunities for individuals to join this research endeavor?

"According to clinicaltrials.gov, recruitment is still open for this trial which was initially posted on June 7th 2023 and modified most recently on November 27th 2023."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients

Jennifer Jones 2023. "90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05686135.

All > Inflammatory Bowel Disease > Ibd